A radical approach to treatment

John L. Cleveland () and Michael B. Kastan ()
Additional contact information
John L. Cleveland: St Jude Children's Research Hospital
Michael B. Kastan: St Jude Children's Research Hospital

Nature, 2000, vol. 407, issue 6802, 309-311

Abstract: A compound that kills leukaemia cells does so by inhibiting an enzyme that keeps down the level of toxic reactive oxygen species. The result raises hope that this compound, together with substances that increase the concentration of these oxygen species, may be useful in treating some cancers.

Date: 2000
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/35030277 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:407:y:2000:i:6802:d:10.1038_35030277

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/35030277

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().